Dallah Healthcare Company (4004.SE)

Also known as:  DHC, Dallah Health
Data delayed by 15 minutes
54.00 SAR 1.001.89%
As of 28 JUL 2020 12:16 GMT|Saudi SE

DHC Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
28.75
Upside
-
Target Price (Mean)
-
52Wk
41.7 16 MAR
54.1 22 JUL

Open
52.90 SAR
Previous Close
54.00 SAR
Turnover
12.55M SAR
EPS
2.032 SAR
Volume
233,915
Transactions
780
Market Cap
3.85B SAR
IPO Date
16-Dec-2012
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Dallah Healthcare CompanyLast updated on: 30 April 2020

Business Summary
Ownership and operation of general hospitals. Through its main subsidiaries, manufacture of branded drugs; distribution of pharmaceuticals; offers hospital and medical center maintenance services.
Country of Incorporation
Ownership Type
Established In
1994
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4004.SSEOrdinarySARSaudi SE4004

Contact details

Primary address
Al Nakheel Tower
King Fahad Road 1157
2nd Floor
Al Nakheel Area
87833
Saudi Arabia
Riyadh
12381
CONTACT
  • Tel: +966 11-299-5555
  • Tel: +966 11-225-5065
  • Tel: +966 11-225-5769
  • Fax: +966 11-470-2748
  • Fax: +966 11-225-0602
  • Fax: +966 11-455-0803
  • Email: www.dallahhealth.com
Region
Riyadh
More
All Press Releases

There may never be a 'silver bullet' for COVID-19: WHO

Despite vaccines in development, the head of the World Health Organization cautioned that the treatments had yet to prove effective and might only convey protection for a short time. This report produced by Zachary Goelman.

Reuters Videos - Monday 3 August 2020
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Ahmad Bin Saleh Mohammed Babaeer
Chief Executive Officer and Managing Director
Mr Khalid Mohammed Ali Al Saudi
Chief Financial Officer
Dr Salah Rashed Al Faqih
Chief of Medical Staff

Board Members

Mr Tariq Othman Abdullah Al Qusabi
Chairman
Mr Mohieddine Saleh Abdullah Kamel
Vice Chairman
Dr Mohammed Rashed Mohammed Al Fagih
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
MOUWASAT MED SEV109.000 SAR5.21
PHARMACEUTICALS31.350 SAR0.64
SAUDI GERMAN HSP33.000 SAR1.38
AL HAMMADI CO25.900 SAR3.19
SULAIMAN ALHABIB88.000 SAR0.57
More

Tuesday Outlook: Asian stocks advance; gold near record high as virus risks remain

Tuesday Outlook: Asian stocks advance; gold near record high as virus risks remain

Dollar's August bounce retraces slightly; oil gives up gains on expected output increase

More

Most Viewed Stocks

Stock Screener

More